Science Translational Medicine
Volume 14| Issue 627| 12 Jan 2022
https://www.science.org/toc/stm/current

Research Articles
GRAd-COV2, a gorilla adenovirus-based candidate vaccine against COVID-19, is safe and immunogenic in younger and older adults
BY Simone Lanini et al.
12 Jan 2022 Open Access
GRAd-COV2, a candidate vaccine for COVID-19 based on a gorilla adenovirus, is safe and immunogenic in younger and older adults.